Their MIST stock forecasts range from $10.00 to $10.00. On average, they expect Milestone Pharmaceuticals' stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 77.6% from the stock's current price.
What are analysts'target prices for Milestone pharmaceuticals (mph) stock?
1 analysts have issued twelve-month target prices for Milestone Pharmaceuticals' shares. Their forecasts range from $20.00 to $20.00. On average, they anticipate Milestone Pharmaceuticals' stock price to reach $20.00 in the next year.
Is milestone pharmaceuticals efficiently growing its dividend?
Milestone Pharmaceuticals does not have a long track record of dividend growth. In the past three months, Milestone Pharmaceuticals insiders have not sold or bought any company stock. Only 5.63% of the stock of Milestone Pharmaceuticals is held by insiders.
How much is a share of milestone scientific worth?
One share of MLSS stock can currently be purchased for approximately $0.93. How much money does Milestone Scientific make? Milestone Scientific (NYSE:MLSS) has a market capitalization of $63.64 million and generates $10.31 million in revenue each year.
Who sold milestone scientific (MLSS) stock in the last quarter?
MLSS stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and Bank of America Corp DE. Company insiders that have sold Milestone Scientific company stock in the last year include Leonard Osser, and Leslie Bernhard.
What is Milestone Pharmaceuticals' ticker symbol?
What is Milestone Pharmaceuticals?
What is MarketBeat community ratings?
Does Milestone Pharmaceuticals pay dividends?
About this website
Should I buy Milestone Pharmaceuticals stock?
There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Milestone Pharmaceuticals stock. View analyst ratings for Milestone Pharmaceuticals or view top-rated stocks.
Is MLSS a good stock to buy?
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk".
Is MIST a good stock to Buy?
The consensus among 1 Wall Street analyst covering (NASDAQ: MIST) stock is to Strong Buy MIST stock.
What is the meaning of MLSS?
Mixed liquor suspended solids2.2 Mixed liquor suspended solids. MLSS are the concentration of suspended solids in mixed liquor, usually expressed in grams per litre (Wateronline, 2011).
How is MLSS calculated?
To calculate the MLVSS of industrial wastewater:Find the flow of the aeration tank in millions of gallons per day.Multiply that value by the COD of the primary effluent in milligrams per liter and 8.34.Divide the value from Step 2 by the food to microorganism ratio in pounds. This result is the MLVSS in pounds.
What is the elaboration of MLSS?
Mixed liquor suspended solids (MLSS) is the concentration of suspended solids, in an aeration tank during the activated sludge process, which occurs during the treatment of waste water.
What is SVI wastewater?
Sludge Volume Index (SVI) is used to describe the settling characteristics of sludge in the aeration tank in Activated Sludge Process. It is a process control parameter to determine the recycle rate of sludge.
Should I buy or sell Milestone Pharmaceuticals stock right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Milestone Pharmaceuticals in the last twelve months. There are cu...
What is Milestone Pharmaceuticals' stock price forecast for 2022?
2 equities research analysts have issued twelve-month target prices for Milestone Pharmaceuticals' shares. Their forecasts range from $10.00 to $10...
How has Milestone Pharmaceuticals' stock performed in 2022?
Milestone Pharmaceuticals' stock was trading at $6.55 at the beginning of the year. Since then, MIST stock has decreased by 11.6% and is now tradin...
When is Milestone Pharmaceuticals' next earnings date?
Milestone Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forec...
How were Milestone Pharmaceuticals' earnings last quarter?
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) issued its earnings results on Thursday, May, 12th. The company reported ($0.33) EPS for the quarter,...
Who are Milestone Pharmaceuticals' key executives?
Milestone Pharmaceuticals' management team includes the following people: Mr. Joseph G. Oliveto M.B.A. , CEO, Pres & Director (Age 54, Pay $908....
Who are some of Milestone Pharmaceuticals' key competitors?
Some companies that are related to Milestone Pharmaceuticals include CTI BioPharma (CTIC) , Verve Therapeutics (VERV) , Avidity Biosciences (RNA...
What other stocks do shareholders of Milestone Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Pharmaceuticals investors own include Sorrento T...
When did Milestone Pharmaceuticals IPO?
(MIST) raised $75 million in an initial public offering on Thursday, May 9th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00...
What is Milestone Scientific's stock price forecast for 2022?
0 Wall Street research analysts have issued 1 year price objectives for Milestone Scientific's shares. Their forecasts range from $4.00 to $4.00. O...
Are investors shorting Milestone Scientific?
Milestone Scientific saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 860,100 shares, a drop of...
When is Milestone Scientific's next earnings date?
Milestone Scientific is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022. View our earnings forecast for...
How were Milestone Scientific's earnings last quarter?
Milestone Scientific Inc. (NYSEAMERICAN:MLSS) posted its earnings results on Tuesday, May, 17th. The medical instruments supplier reported ($0.03)...
Who are Milestone Scientific's key executives?
Milestone Scientific's management team includes the following people: Mr. Jan Adriaan Haverhals , Pres & CEO (Age 60, Pay $649.82k) Mr. Leonard...
Who are some of Milestone Scientific's key competitors?
Some companies that are related to Milestone Scientific include Sanara MedTech (SMTI) , Lakeland Industries (LAKE) , United Health Products (UEE...
What other stocks do shareholders of Milestone Scientific own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include Fortinet (FTNT)...
What is Milestone Scientific's stock symbol?
Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."
Who are Milestone Scientific's major shareholders?
Milestone Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include Sequoia Financial Advi...
When will Milestone Scientific release its earnings?
Milestone Scientific is scheduled to release its next quarterly earnings announcement on Friday, August 13th 2021. View our earnings forecast for Milestone Scientific.
What is Milestone Scientific's stock symbol?
Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."
What guidance has Milestone Scientific issued on next quarter's earnings?
Milestone Scientific updated its FY 2021 earnings guidance on Monday, February, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $10 M-, compared to the consensus revenue estimate of $9.88 million.
What other stocks do shareholders of Milestone Scientific own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include Fortinet (FTNT), Cellectar Biosciences (CLRB), Eldorado Gold (EGO), Advanced Micro Devices (AMD), Plug Power (PLUG), Vista Gold (VGZ), Ampio Pharmaceuticals (AMPE), Amarin (AMRN), Avadel Pharmaceuticals (AVDL) and Enterprise Products Partners (EPD).
How much money does Milestone Scientific make?
Milestone Scientific has a market capitalization of $91.59 million and generates $5.44 million in revenue each year. The medical instruments supplier earns $-7.34 million in net income (profit) each year or ($0.09) on an earnings per share basis.
What is Marketbeat community ratings?
MarketBeat's community ratings are surveys of what our community members think about Milestone Scientific and other stocks. Vote “Outperform” if you believe MLSS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MLSS will underperform the S&P 500 over the long term. You may vote once every thirty days.
What is the P/E ratio of Milestone Scientific?
The P/E ratio of Milestone Scientific is -27.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What is Milestone Pharmaceuticals' ticker symbol?
Milestone Pharmaceuticals trades on the NASDAQ under the ticker symbol "MIST."
What is Milestone Pharmaceuticals?
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF), and rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.
What is MarketBeat community ratings?
MarketBeat's community ratings are surveys of what our community members think about Milestone Pharmaceuticals and other stocks. Vote “Outperform” if you believe MIST will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MIST will underperform the S&P 500 over the long term. You may vote once every thirty days.
Does Milestone Pharmaceuticals pay dividends?
Milestone Pharmaceuticals does not currently pay a dividend.
